Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Impact of Intravenous Iron (Ferinject) on Musculoskeletal Function Profiles in Older Adults With Iron Deficiency Anaemia (IDA)
Authors not listed
Liverpool Hope University · 2023
Abstract
Anaemia is a risk factor for functional decline and frailty in older adults including decreased physical performance and muscle strength, increased hospitalisation risk and mortality, falls, and poorer recovery from activities of daily living. Despite a major gap in human studies, research in animals has demonstrated an interrelationship between iron deficiency anaemia and deteriorated functional capacity and physical performance particularly in older adults. Iron deficiency and associated anaemia is a frequent accompanier of debilitating chronic diseases such as heart failure and chronic lung diseases. These conditions, more commonly seen in older patients, are strongly linked to deterioration in physical function, reduced skeletal muscle mass and quality, frailty, and poor quality of life. Exercise intolerance is also a common feature of these conditions as iron deficiency impairs the capacity of carrying oxygen leading to inability to sustain physical activities. Furthermore, the age-related decline in the muscle mass and quality (so called sarcopenia) and associated frailty has rapidly become a major health concern in the older adults particularly when accompanied by other chronic diseases. Recently, there has been an increasing interest in exploring the role of iron as a causative factor in the development of sarcopenia and related frailty.
In summary, there is a substantial gap of evidence whether Iron repletion leads to meaningful enhancements in the skeletal muscle function and physical performance in older adults suffering from iron deficiency anaemia. This study will investigate the impact of a standard care intervention (intravenous iron therapy) on muscular function and physical performance in older patients through a range of laboratory assessments.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
Anonymous. (2023). Impact of Intravenous Iron (Ferinject) on Musculoskeletal Function Profiles in Older Adults With Iron Deficiency Anaemia (IDA). <em>Liverpool Hope University</em>. https://clinicaltrials.gov/study/NCT05708170
Vancouver
Anonymous. Impact of Intravenous Iron (Ferinject) on Musculoskeletal Function Profiles in Older Adults With Iron Deficiency Anaemia (IDA). Liverpool Hope University. 2023.
BibTeX
@misc{anon2023Impact,
title = {Impact of Intravenous Iron (Ferinject) on Musculoskeletal Function Profiles in Older Adults With Iron Deficiency Anaemia (IDA)},
author = {Anonymous},
journal = {Liverpool Hope University},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Hospices Civils de Lyon 2018
Open access · US-GOV
Impact of Physical Rehabilitation on Sarcopenia Inolder and Chronic Kidney Patients
National Taiwan University Hospital 2024
Open access · US-GOV
Assessing the Efficacy of a Muscle Strength Training Intervention for Sarcopenia in Middle-aged and Elderly Individuals
Acibadem University 2021
Open access · US-GOV
Prevelance of Frailty and Its Associated Factors in Patients With Axial Spondyloarthritis
Frontiers in Rehabilitation Sciences 2022
Open access · CC-BY
Klotho: An Emerging Factor With Ergogenic Potential
Escola Superior de Saúde - Universidade do Algarve 2026
Open access · US-GOV
Effects of Magnesium Supplementation on Muscle Strength, Muscle Mass, and Physical Performance in Sarcopenic Individuals
Mersin University 2024
Open access · US-GOV